Table 1.
Baseline clinical and demographic characteristics of patients receiving sitamaquine and amphotericin B for treatment of visceral leishmaniasis, Bihar, India*
| Characteristic | Sitamaquine (n = 41) | Amphotericin B (n = 20) |
|---|---|---|
| Age, years | 27.5 (9.7), 16–50 | 29.9 (9.3), 19–47 |
| Weight, kg | 44.2 (7.9), 30–69 | 46.8 (6.2), 35–58 |
| Height, cm | 158.8 (7.6) | 163.2 (7.0) |
| Male sex, no. (%) | 23 (56) | 13 (65) |
| Leishmaniasis index | 1.9 (0.8) | 2.0 (0.7) |
| No. (%) patients with following Leishmania index | ||
| 1 | 13 (32) | 5 (25) |
| 2 | 20 (49) | 11 (55) |
| 3 | 7 (17) | 4 (20) |
| 4 | 1 (2) | 0 |
| Spleen size, cm | 15.1 (2.2) | 14.4 (3.0) |
| Temperature, °C | 37.7 (0.9) | 37.0 (0.7) |
| Patients febrile up to day (≥ 38°C), no. positive/no. tested (%) | 23/41 (56) | 10/20 (50) |
*
Values are mean (SD), range unless otherwise indicated.